Company Interview / Quantum leap: Archer Materials' tech breakthrough

Simon Ruffell of Archer Materials highlights a breakthrough in quantum technology, with its carbon-based semiconductor, 12CQ, advancing applications in computing and medical sensing. Simon reveals that Archer is the only ASX-listed company focusing on this tech.

He explains the promise of biochips using graphene for rapid diagnostics. These chips are set to improve disease management, offering patients and clinicians immediate results, particularly in chronic kidney disease management.

Simon mentions Archer's ongoing commercial partnerships and a collaboration with a China-based firm to produce magnetic sensors. Commercialisation steps include demonstrating biochip feasibility and engaging with regulatory bodies for approval.